Belpointe Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,200	Closed	-$12.9K	–	2070
2023 Q1	$12.9K	Hold	1,200	–	–	﹤0.01%	2568
2022 Q4	$18K	Buy	+1,200	New	+$18K	﹤0.01%	2260